Long-acting injectable Cabotegravir (CAB-LA) pilot implementation at primary healthcare level in resource-limited settings: early real-world evidence from the USAID DISCOVER-Health Project in Zambia

Conference Reports for NATAP

HIVR4P 2024
5th HIV Research for
Prevention Conference
Lima, Peru - Oct 6-10 2024


Long-acting injectable Cabotegravir (CAB-LA) pilot implementation at primary healthcare level in resource-limited settings: early real-world evidence from the USAID DISCOVER-Health Project in Zambia

	Adamson Paxon Ndhlovu